The novel approach of the medication represents a significant advance in the handling of diabetes mellitus type 2. Different to existing medications, tirzepatide targets two pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide338823.dailyblogzz.com/42497749/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment